发明名称 PYRAZOLOPYRIDINE COMPOUND AND PHARMACEUTICAL USE THEREOF
摘要 A pyrazolopyridine compound of formula (I) wherein R<1> is aryl, and R<2> is lower alkyl substituted with unsaturated 3 to 8-membered heteromonocyclic group containing 1 or 2 sulfur atom(s) and 1 to 3 nitrogen atom(s) which may have one or more substituent(s); a group of formula (1) wherein R<3> is hydrogen, lower alkyl, ar(lower)alkyl or acyl, R<4> is hydrogen or hydroxy, A is lower alkylene, m is an integer of 0 or 1, and n is an integer of 1 or 2; a group of formula (2) wherein R<5> and R<6> are each lower alkyl; or quinuclidinyl, or a salt thereof. The pyrazolopyridine compound (I) and a salt thereof of the present invention are adenosine antagonists and are useful for the prevention and/or treatment of depression, dementia (e.g. Alzheimer's disease, cerebrovascular dementia, Parkinson's disease, etc.), anxiety, pain, cerebrovascular disease (e.g. stroke, etc.), heart failure, and the like.
申请公布号 WO9803507(A1) 申请公布日期 1998.01.29
申请号 WO1997JP02493 申请日期 1997.07.17
申请人 FUJISAWA PHARMACEUTICAL CO., LTD.;AKAHANE, ATSUSHI;KURODA, SATORU;ITANI, HIROMICHI;SHIMIZU, YASUYO 发明人 AKAHANE, ATSUSHI;KURODA, SATORU;ITANI, HIROMICHI;SHIMIZU, YASUYO
分类号 A61K31/501;A61P1/04;A61P3/10;A61P9/00;A61P11/06;A61P13/12;A61P25/00;A61P37/06;A61P43/00;C07D471/04;(IPC1-7):C07D471/04;C07D453/02;A61K31/50 主分类号 A61K31/501
代理机构 代理人
主权项
地址